Shree Pacetronix Ltd (527005)

Shree Pacetronix Limited has confirmed that there were no deviations or variations in the utilization of funds raised through its preferential issue for the quarter ended June 30, 2026. The company raised a total of Rs. 243.48 Lakhs through a combination of equity shares and warrants issued between November 2025 and March 2026. Of this, Rs. 152.18 Lakhs was received at the time of allotment, with subsequent inflows from warrant conversions. The Audit Committee has reviewed and taken the statement on record, ensuring compliance with SEBI's Regulation 32.

• Total amount raised through preferential issue and warrants stands at Rs. 243.48 Lakhs.
• Initial amount received at the time of allotment was Rs. 152.18 Lakhs.
• Conversion of 75,150 Series A warrants on March 20, 2026, contributed Rs. 45.65 Lakhs.
• Upfront receipt of 25% for Series B warrants (150,300 units) amounted to Rs. 30.43 Lakhs.
• Zero deviation reported in the use of funds as per the objects approved by shareholders.

Shree Pacetronix has approved the re-appointment of Mr. Akash Sethi as Joint Managing Director for a 3-year term effective August 14, 2027. Additionally, the board re-appointed two Independent Directors, Ms. Manali Tongia and Ms. Somya Chhabra, for second 5-year terms starting in March and May 2027, respectively. These decisions, made during the August 13, 2026 board meeting, are subject to shareholder approval at the upcoming Annual General Meeting. The company remains a small-cap entity with a market capitalization of Rs 50 Cr and TTM revenue of Rs 22 Cr.

• Mr. Akash Sethi re-appointed as Joint Managing Director for a 3-year term (2027-2030)
• Two Independent Directors re-appointed for 5-year terms each extending to 2032
• Promoter holding increased from 24.25% in June 2025 to 31.7% in March 2026
• Company reported a TTM PAT of Rs 3 Cr with an Operating Profit Margin of 24.2%

Shree Pacetronix has approved the re-appointment of Mr. Akash Sethi as Joint Managing Director for a three-year term effective from August 14, 2027. Additionally, the board approved second five-year terms for Independent Directors Ms. Manali Tongia and Ms. Somya Chhabra, starting in March and May 2027, respectively. These decisions, made during the August 13, 2026 board meeting, aim to ensure leadership continuity for the Rs 50 Cr market cap medical equipment company. All re-appointments are subject to shareholder approval at the upcoming Annual General Meeting.

• Mr. Akash Sethi re-appointed as Joint Managing Director for a 3-year term from August 14, 2027, to August 13, 2030.
• Ms. Manali Tongia re-appointed as Independent Director for a 5-year term from March 24, 2027, to March 23, 2032.
• Ms. Somya Chhabra re-appointed as Independent Director for a 5-year term from May 6, 2027, to May 5, 2032.
• Mr. Akash Sethi holds a Master of Science from Carnegie Mellon University and has over 8 years of industry experience.
• Promoter holding in the company has increased from 24.25% in June 2025 to 31.7% as of March 2026.

Shree Pacetronix Ltd has announced its 38th Annual General Meeting (AGM) scheduled for September 29, 2026. The company will implement a book closure period from September 23 to September 29, 2026, to determine shareholder eligibility for the meeting. This is a standard regulatory filing providing e-voting facilities as per SEBI (LODR) Regulations. The company currently operates with a small market capitalization of Rs 50 Cr and reported a TTM revenue of Rs 22 Cr.

• 38th Annual General Meeting scheduled for September 29, 2026, at 1:00 P.M.
• Book closure period defined from September 23, 2026, to September 29, 2026 (both days inclusive).
• Promoter holding has increased significantly from 24.25% in June 2025 to 31.7% in March 2026.
• Company reported a TTM PAT of Rs 3 Cr on a revenue base of Rs 22 Cr.

Shree Pacetronix Ltd has announced its 38th Annual General Meeting (AGM) to be held on September 29, 2026, at its registered office in Pithampur. In accordance with SEBI regulations, the Register of Members will remain closed from September 23 to September 29, 2026. This is a standard administrative procedure for the company, which reported a TTM revenue of Rs 22 Cr and a PAT of Rs 3 Cr. Investors should monitor the AGM for any management commentary on the significant margin expansion seen in FY26 (OPM 24.2% vs 14% in FY25).

• 38th Annual General Meeting scheduled for September 29, 2026, at 1:00 P.M.
• Book closure period set for 7 days from September 23, 2026, to September 29, 2026.
• Company reported FY26 revenue of Rs 21.64 Cr, a 29.7% increase over FY25.
• Promoter holding has increased from 24.25% in June 2025 to 31.7% in March 2026.

Shree Pacetronix reported a mixed Q1 FY27 with standalone revenue declining 8.2% YoY to ₹4.90 Cr. Despite the top-line dip, Profit After Tax (PAT) grew 13.4% YoY to ₹0.76 Cr, primarily driven by a 78.7% reduction in finance costs. Sequentially, performance was weaker with revenue and PAT falling 8.7% and 21.6% respectively compared to Mar 2026. A significant highlight is the increase in promoter holding to 36.44% from 31.7% in the previous quarter.

• Revenue from operations decreased 8.2% YoY to ₹4.90 Cr from ₹5.34 Cr in Jun 2025.
• Net Profit (PAT) increased 13.4% YoY to ₹0.76 Cr, up from ₹0.67 Cr in the year-ago period.
• Finance costs saw a sharp reduction of 78.7% YoY, falling to ₹2.42 Lakhs from ₹11.38 Lakhs.
• Promoter non-encumbered holding increased to 33.00% from 28.26% in the previous quarter.
• Total expenses were contained at ₹3.90 Cr versus ₹4.47 Cr in Q1 FY26, a 12.7% reduction.

Shree Pacetronix held its board meeting on August 13, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026. The board approved the re-appointment of Mr. Akash Sethi as Joint Managing Director for a three-year term (2027-2030) and two independent directors for five-year terms. Additionally, the board approved an increase in remuneration for the Joint MD, subject to shareholder approval at the upcoming 38th AGM on September 29, 2026. The company, with a market cap of Rs 50 Cr, maintains a strong OPM of 24.2% as per TTM figures.

• Re-appointment of Mr. Akash Sethi as Joint Managing Director for a 3-year term from August 14, 2027, to August 13, 2030.
• 38th Annual General Meeting (AGM) scheduled for September 29, 2026, at 01:00 P.M.
• Book closure period fixed from September 23, 2026, to September 29, 2026, for AGM purposes.
• Re-appointment of two Independent Directors, Ms. Manali Tongia and Ms. Somya Chhabra, for second 5-year terms.
• Approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Shree Pacetronix has scheduled a board meeting on August 13, 2026, to approve its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company enters this quarter following a strong FY26, where annual revenue grew 29.7% to Rs 21.64 crore compared to Rs 16.68 crore in FY25. With a current market capitalization of Rs 53 crore and a TTM P/E of 16.8, investors will be watching for consistency in operating margins, which averaged 24.2% over the last twelve months. The trading window for insiders has been closed since July 1, 2026, as per regulatory requirements.

• Board meeting set for August 13, 2026, to consider Q1 FY27 financial results.
• Trading window for designated persons closed from July 1, 2026, until 48 hours post-result declaration.
• Company reported a TTM PAT of Rs 3 crore on a TTM revenue base of Rs 22 crore.
• Promoter holding has seen a recent increase to 31.7% as of March 2026, up from 24.25% in June 2025.
• The meeting will be held at the company's registered office in Pithampur, Madhya Pradesh.